Fred Tasker, Miami Herald and WLRN s Wine Guy, dies at 79 He took readers around the world yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Johns Hopkins Medicine researchers have shown that although two doses of a vaccine against SARS-CoV-2 the virus that causes COVID-19 confers some protection for people who have. view more
Credit: Graphic created by M.E. Newman, Johns Hopkins Medicine, with public domain images and background transplant surgery photograph courtesy of Johns Hopkins Medicine
Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 the virus that causes COVID 19 confers some protection for people who have received solid organ transplants, it s still not enough to enable them to dispense with masks, physical distancing and other safety measures.
COVID Control using self-reported virus symptom information could predict next outbreak.
A mobile app that uses crowd-sourced data on COVID-19 symptoms can accurately identify where local coronavirus outbreaks will appear, according to Johns Hopkins Medicine scientists who developed the app.
The Johns Hopkins team launched the COVID Control app in May 2020 and have been studying how user-reported COVID-19 symptoms can predict potential outbreaks of the virus, enabling public health leaders to enact measures to contain the virus spread. Results of the researchers findings were published February 25, in Nature It s a really promising example of how we can use public participation and the ubiquity of technology like cell phones to track disease, says Robert Stevens, M.D., director of anesthesiology and critical care precision medicine at the Johns Hopkins University School of Medicine. It s not limited to infectious diseases. This could be used to track the epidemiology of
Bayer extends research agreement with Hopkins through 2024
The pharmaceuticals and life sciences company will continue its partnership with Johns Hopkins to provide funding to researchers in the Wilmer Eye Institute
Credit: Wikimedia Commons May 6, 2021
The Johns Hopkins University and Bayer AG have extended their strategic research alliance in ophthalmology through the end of 2024. The agreement will provide multimillion-dollar funding for researchers at the Johns Hopkins Wilmer Eye Institute to pursue treatments for a variety of eye diseases and ailments while benefitting from the expertise of Bayer scientists about potential drug candidates.
A drug candidate from one of the collaboration s programs has advanced to a phase II clinical trial and another program is licensed to a startup company. Researchers on both sides hope to translate the joint research into improved vision by moving innovative treatments from labs to patients eyes.
The promise and peril of central bank digital currencies
May 05,2021 - Last updated at May 05,2021
WASHINGTON, DC Bitcoin and other privately issued cryptocurrencies have generated a frenzy of excitement, with most of the analysis focused on their appeal and apparent drawbacks. But relatively less attention has been paid to an even more important development: The increasing likelihood that countries will shift partly or entirely to a central bank digital currency (CBDC).
Economists have long recognised that money performs three functions. As a medium of exchange, it enables transactions that otherwise would require difficult bartering (as in trading chickens for a car). As a unit of account, it allows one to know whether one has saved or dissaved over the past year. And as a store of value, money enables current income to finance future purchases.